» Articles » PMID: 35253069

Role of 5-HT Receptors in the Effects of Ayahuasca on Ethanol Self-administration Using a Two-bottle Choice Paradigm in Male Mice

Abstract

Rationale: Ayahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT receptor agonist N,N-dimethyltryptamine (DMT) is the main psychoactive component of ayahuasca, suggesting that its therapeutic effects may be mediated by 5-HT receptors.

Objectives: The aim of the present study was to investigate the effects of ayahuasca on the expression of ethanol self-administration using a two-bottle choice procedure and the role of 5-HT receptors in those effects.

Methods: Male mice had intermittent access to ethanol (10% v/v) in a two-bottle choice procedure for 30 days. Animals were then submitted to 3 treatment phases, each followed by ethanol re-exposure tests. During the treatment phase, every 3 days, animals received i.p. injections of either vehicle or the 5-HT receptor antagonist M100907 (M100, 1 mg/kg) followed by an i.g. (gavage) administration of vehicle or ayahuasca (100 mg/kg) and were exposed to the self-administration apparatus with no ethanol availability. During re-exposure tests, animals were submitted to the same conditions as during acquisition, with no treatments prior to those sessions.

Results: Treatment with ayahuasca blocked the expression of ethanol self-administration, decreasing ethanol intake and preference during re-exposure tests. Pretreatment with M100 blocked the effects of ayahuasca on ethanol drinking without significantly attenuating ethanol self-administration.

Conclusions: Treatment with ayahuasca during alcohol abstinence blocked the expression of alcohol self-administration in mice, and 5-HT receptor activation is critical for those effects to emerge. Our findings support a potential for ayahuasca and other 5-HT receptor agonists as adjunctive pharmacotherapies for the treatment of AUD.

Citing Articles

Ayahuasca drinking using a two-bottle choice procedure in male mice.

Kisaki N, Serra Y, Rodrigues I, Silva K, Jovita-Farias C, Alves G Sci Rep. 2024; 14(1):25064.

PMID: 39443587 PMC: 11499999. DOI: 10.1038/s41598-024-75077-x.


Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies.

Hilal F, Jeanblanc J, Deschamps C, Naassila M, Pierrefiche O, Ben Hamida S J Neural Transm (Vienna). 2024; 131(5):525-561.

PMID: 38554193 DOI: 10.1007/s00702-024-02757-3.


The role of brain serotonin signaling in excessive alcohol consumption and withdrawal: A call for more research in females.

Castle M, Flanigan M Neurobiol Stress. 2024; 30:100618.

PMID: 38433994 PMC: 10907856. DOI: 10.1016/j.ynstr.2024.100618.


Trait sensitivity to positive feedback is a predisposing factor for several aspects of compulsive alcohol drinking in male rats: behavioural, physiological, and molecular correlates.

Cieslik-Starkiewicz A, Noworyta K, Solich J, Korlatowicz A, Faron-Gorecka A, Rygula R Psychopharmacology (Berl). 2023; 241(1):33-47.

PMID: 37682294 PMC: 10774643. DOI: 10.1007/s00213-023-06460-1.


Therapeutic mechanisms of psychedelics and entactogens.

Heifets B, Olson D Neuropsychopharmacology. 2023; 49(1):104-118.

PMID: 37488282 PMC: 10700553. DOI: 10.1038/s41386-023-01666-5.


References
1.
Cata-Preta E, Serra Y, Moreira-Junior E, Reis H, Kisaki N, Libarino-Santos M . Ayahuasca and Its DMT- and β-carbolines - Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment. Front Pharmacol. 2018; 9:561. PMC: 5986901. DOI: 10.3389/fphar.2018.00561. View

2.
Thomas G, Lucas P, Capler N, Tupper K, Martin G . Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada. Curr Drug Abuse Rev. 2013; 6(1):30-42. DOI: 10.2174/15733998113099990003. View

3.
McKenna D . Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacol Ther. 2004; 102(2):111-29. DOI: 10.1016/j.pharmthera.2004.03.002. View

4.
Nolli L, de Oliveira D, Alves S, von Zuben M, Pic-Taylor A, Mortari M . Effects of the hallucinogenic beverage ayahuasca on voluntary ethanol intake by rats and on cFos expression in brain areas relevant to drug addiction. Alcohol. 2019; 84:67-75. DOI: 10.1016/j.alcohol.2019.10.005. View

5.
Berquist M, Fantegrossi W . Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long-Evans rats. Behav Pharmacol. 2021; 32(5):382-391. PMC: 8266736. DOI: 10.1097/FBP.0000000000000628. View